2024年11月8日,万基遗传公司(MYGN)盘前股价大涨5.38%,报收25.39美元。这一大涨或许与该公司近期公布的季度业绩表现亮眼有关。
万基遗传公司公布的截至2024年9月30日的季度每股收益为6美分,高于分析师预期的2美分,去年同期为亏损3美分。当季度营收也同比增长11.2%,达到2.133亿美元,超过分析师的预期。
虽然该公司当季度净亏损2210万美元,但由于优于预期的业绩,加上分析师对未来利润预期的上调,投资者对公司前景预期向好,从而推动了公司股价的大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.